Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Operating Expenses (2011 - 2026)

Updated

Vistagen Therapeutics' Operating Expenses came in at $14.82 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 7.6% from $16.05 million a year earlier and down 13.7% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Operating Expenses (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vistagen Therapeutics reported Operating Expenses of $72.17 million, up 19.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $73.4 million, up 30.0% from FY2025.

  • Operating Expenses carries a five-year compound annual growth rate of 31.0% (FY2021 to FY2026).
  • Going back by fiscal year, Operating Expenses was $56.46 million in FY2025 (+65.6%), $34.09 million in FY2024 (-42.3%), $59.04 million in FY2023 (+20.8%) and $48.89 million in FY2022 (+157.0%).
  • The fiscal Q1 2027 figure represents the lowest quarterly Operating Expenses since fiscal Q4 2025.
  • Year-over-year, Operating Expenses increased in seven of the last eight quarters, with growth averaging 40.9%.
  • The fastest year-over-year change in Operating Expenses over five years came in fiscal Q2 2022 (growth of 262.7%), and the weakest in fiscal Q1 2024 (a decline of 64.3%).
  • Business Quant data shows VTGN's Operating Expenses at $17.18 million (Q4 2026), $19.85 million (Q3 2026) and $20.31 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - 14.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.82 Mn
Mar 31, 2026 17.18 Mn
Dec 31, 2025 19.85 Mn
Sep 30, 2025 20.31 Mn
Jun 30, 2025 16.05 Mn
Mar 31, 2025 14.48 Mn
Dec 31, 2024 15.35 Mn
Sep 30, 2024 14.41 Mn
Jun 30, 2024 12.22 Mn
Mar 31, 2024 11.56 Mn
Dec 31, 2023 8.30 Mn
Sep 30, 2023 7.06 Mn
Jun 30, 2023 7.18 Mn
Mar 31, 2023 12.42 Mn
Dec 31, 2022 9.95 Mn
Sep 30, 2022 16.60 Mn
Jun 30, 2022 20.08 Mn
Mar 31, 2022 16.73 Mn
Dec 31, 2021 10.90 Mn
Sep 30, 2021 13.16 Mn
API Access

Vistagen Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY